Clinical validation of image-based AI predictive biomarkers for precision neoadjuvant triple-negative breast cancer treatment (PEAR-TNBC)

被引：0
|
作者：
Williams, Matthew
Peerani, Eleonora
Tham, Elli
Iori, Francesco
de Fraine, George Richard Tiger Bevan
Loughrey, Kerrie
Kaffa, Andreas Dimitri
Richardson, Thomas David Laurent
Liberal, Carolina
Velentza-Almpani, Angeliki
Wiskerke, Demi Annemarie
Sangkolah, Farah
Crawley, Aston Martin
Kearney, Jay
Molina, Edgar Giussepi Lopez
Bah, Nourdine Kabirou
Tasoulis, Marios Konstantinos
Kirwan, Cliona C.
Ranatunga, Duleek Nimantha Bandara
Hall, Peter Edward
机构：
[1] Ourotech Ltd T A Pear Bio, London, England
[2] Royal Marsden NHS Fdn Trust, London, England
[3] Manchester Univ Fdn Trust, Manchester, Lancs, England
[4] Barts Canc Ctr, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS627
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Transcriptomic modification induced by the first cycle of neoadjuvant chemotherapy impacts response to treatment in triple-negative breast cancer (TNBC)
    Desmoulins, I.
    Chardin, D.
    Richard, C.
    Arnould, L.
    Boidot, R.
    Humbert, O.
    ANNALS OF ONCOLOGY, 2021, 32 : S494 - S494
  • [22] Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancer
    Han, Yiqun
    Wang, Jiayu
    Xu, Binghe
    JOURNAL OF CANCER, 2021, 12 (03): : 936 - 945
  • [23] Exosomal miRNA profiles of triple-negative breast cancer in neoadjuvant treatment
    Sueta, Aiko
    Fujiki, Yoshitaka
    Goto-Yamaguchi, Lisa
    Tomiguchi, Mai
    Yamamoto-Ibusuki, Mutsuko
    Iwase, Hirotaka
    Yamamoto, Yutaka
    ONCOLOGY LETTERS, 2021, 22 (06)
  • [24] Therapeutic pattern and progress of neoadjuvant treatment for triple-negative breast cancer
    Xiao, Yan
    Gao, Wencheng
    ONCOLOGY LETTERS, 2022, 24 (01)
  • [25] Clinical Characteristics and Management of Triple-Negative Breast Cancer (TNBC) in Jordan: A Retrospective Analysis
    Al Husban, Hussein
    Al Rabadi, Anas
    Odeh, Ala H.
    Abu Rumman, Kahled
    Alkhawaldeh, Feras
    Noures, Haneen
    Ashoor, Mohammad Abo
    Abu Rumman, Anas
    Atmeh, Mousa
    Bawaneh, Mohannad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [26] Triple-negative breast cancer: bridging the gap from cancer genomics to predictive biomarkers
    Davis, S. Lindsey
    Eckhardt, S. Gail
    Tentler, John J.
    Diamond, Jennifer R.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (03) : 88 - 100
  • [27] Emerging Predictive Biomarkers of Response to Platinum Therapy in Triple-Negative Breast Cancer
    Mego M.
    Reuben J.M.
    Current Breast Cancer Reports, 2015, 7 (4) : 224 - 231
  • [28] Molecular biomarkers as predictive factors of pCR for early triple-negative breast cancer
    Ghanem, Ismael
    Castaneda, Carlos
    Perez-Campos, Ana
    Toldos, Oscar
    Sancho Perez, Blanca
    Manso, Luis
    Luis Rodriguez-Peralto, Jose
    Calderon, Monica
    Corles-Funes, Herman
    Lora, David
    Garcia-Martin, Rosa
    Ciruelos, Eva
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC).
    Walsh, Elaine M.
    O'Loughlin, Mark
    Shalaby, Aliaa
    Webber, Mark
    Kerin, Michael J.
    Glynn, Sharon A.
    Callagy, Grace
    Keane, Maccon M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Intrinsic subtype and response to neoadjuvant chemotherapy with carboplatin and docetaxel (TCb) in triple-negative breast cancer (TNBC)
    Echavarria Diaz-Guardamino, I.
    Lopez-Tarruella, S.
    Garcia-Saenz, J. A.
    Gomez Moreno, H.
    Moreno, F.
    Jerez, Y.
    Fuentes, H.
    Marquez-Rodas, I.
    Cebollero, M.
    Del Monte-Millan, M.
    Picornell, A.
    Massarrah, T.
    Barnadas, A.
    Prat, A.
    Ballesteros Garcia, A.
    Colomer Bosch, R.
    Pelaez, B.
    Gonzalez-Rivera, M.
    Perou, C. M.
    Martin, M.
    ANNALS OF ONCOLOGY, 2016, 27
12345